Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvia miltiorrhiza injection plus telmisartan in diabetic nephropathy
ChiCTR-IPR-17011581Phase 4Completed
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in diabetic glomerulosclerosis comparing Telmisartan group, Salvia miltiorrhiza injection + Telmisartan group and Placebo group (3 arms). Primary endpoints: Collagen IV and Fibronectin. Started Oct 2015; status: completed.
02
Drugs
telmisartansalvia miltiorrhiza
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-17011581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011581.